Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways

BACKGROUND: The novel small molecule R118 and the biguanide metformin, a first-line therapy for type 2 diabetes (T2D), both activate the critical cellular energy sensor 5′-AMP-activated protein kinase (AMPK) via modulation of mitochondrial complex I activity. Activation of AMPK results in both acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Yonchu, Sun, Tian-Qiang, Li, Yingwu, Markovtsov, Vadim, Uy, Gerald, Gross, Lisa, Goff, Dane A, Shaw, Simon J, Boralsky, Luke, Singh, Rajinder, Payan, Donald G, Hitoshi, Yasumichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182811/
https://www.ncbi.nlm.nih.gov/pubmed/25252968
http://dx.doi.org/10.1186/1756-0500-7-674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182811/
https://www.ncbi.nlm.nih.gov/pubmed/25252968
http://dx.doi.org/10.1186/1756-0500-7-674

Ejemplares similares